Successful Treatment of Rheumatoid Pleural Effusion with Sarilumab
Author Information
Author(s): Muacevic Alexander, Adler John R, Sunaga Atsuhiko, Inoue Takuya
Primary Institution: Department of Rheumatology, Matsushita Memorial Hospital, Moriguchi-shi, JPN
Hypothesis
Can sarilumab effectively treat refractory rheumatoid pleural effusion in patients with rheumatoid arthritis?
Conclusion
Sarilumab was effective in achieving remission of both rheumatoid pleural effusion and arthritis in the patient.
Supporting Evidence
- The patient did not respond to prednisolone therapy before starting sarilumab.
- Arthritis and pleural effusion resolved after six weeks of sarilumab treatment.
- Sustained remission was observed 14 months after initiating sarilumab therapy.
Takeaway
A 68-year-old man with a rare lung problem caused by arthritis got better after taking a medicine called sarilumab.
Methodology
Case report detailing the treatment of a patient with rheumatoid arthritis and refractory pleural effusion using sarilumab.
Limitations
Only one case is reported, limiting generalizability.
Participant Demographics
68-year-old male with a history of smoking.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website